A design strategy for drug-like polyheterocycles with privileged substructures for discovery of specific small-molecule modulators S Oh, SB Park Chemical Communications 47 (48), 12754-12761, 2011 | 157 | 2011 |
Transcriptional corepressor SMILE recruits SIRT1 to inhibit nuclear receptor estrogen receptor-related receptor γ transactivation YB Xie, JH Park, DK Kim, JH Hwang, S Oh, SB Park, M Shong, IK Lee, ... Journal of Biological Chemistry 284 (42), 28762-28774, 2009 | 76 | 2009 |
Discovery and target identification of an antiproliferative agent in live cells using fluorescence difference in two‐dimensional gel electrophoresis J Park, S Oh, SB Park Angewandte Chemie 124 (22), 5543-5547, 2012 | 74 | 2012 |
MAIT cell-directed therapy of Mycobacterium tuberculosis infection S Sakai, KD Kauffman, S Oh, CE Nelson, CE Barry III, DL Barber Mucosal immunology 14 (1), 199-208, 2021 | 72 | 2021 |
Synthesis and biological evaluation of 2, 3-dihydroimidazo [1, 2-a] benzimidazole derivatives against Leishmania donovani and Trypanosoma cruzi S Oh, S Kim, S Kong, G Yang, N Lee, D Han, J Goo, JL Siqueira-Neto, ... European Journal of Medicinal Chemistry 84, 395-403, 2014 | 63 | 2014 |
Construction of a polyheterocyclic benzopyran library with diverse core skeletons through diversity-oriented synthesis pathway S Oh, HJ Jang, SK Ko, Y Ko, SB Park Journal of Combinatorial Chemistry 12 (4), 548-558, 2010 | 55 | 2010 |
Tuberculosis drug discovery: A decade of hit assessment for defined targets S Oh, L Trifonov, VD Yadav, CE Barry III, HI Boshoff Frontiers in Cellular and Infection Microbiology 11, 611304, 2021 | 52 | 2021 |
Antidiabetic and Antiobesity Effects of Ampkinone (6f), a Novel Small Molecule Activator of AMP-Activated Protein Kinase S Oh, SJ Kim, JH Hwang, HY Lee, MJ Ryu, J Park, SJ Kim, YS Jo, YK Kim, ... Journal of medicinal chemistry 53 (20), 7405-7413, 2010 | 46 | 2010 |
Anti-obesity agents: a focused review on the structural classification of therapeutic entities S Oh, KS Kim, YS Chung, M Shong, SB Park Current topics in medicinal Chemistry 9 (6), 466-481, 2009 | 37 | 2009 |
Activating mucosal-associated invariant T cells induces a broad antitumor response B Ruf, VV Catania, S Wabitsch, C Ma, LP Diggs, Q Zhang, B Heinrich, ... Cancer immunology research 9 (9), 1024-1034, 2021 | 35 | 2021 |
Discovery of carbohybrid-based 2-aminopyrimidine analogues as a new class of rapid-acting antimalarial agents using image-based cytological profiling assay S Lee, D Lim, E Lee, N Lee, H Lee, J Cechetto, M Liuzzi, ... Journal of Medicinal Chemistry 57 (17), 7425-7434, 2014 | 35 | 2014 |
Discovery and Structure–Activity-Relationship Study of N-Alkyl-5-hydroxypyrimidinone carboxamides as novel antitubercular agents targeting decaprenylphosphoryl-β-d-ribose 2 … S Oh, Y Park, CA Engelhart, JB Wallach, D Schnappinger, K Arora, ... Journal of Medicinal Chemistry 61 (22), 9952-9965, 2018 | 34 | 2018 |
Nonspecific protein labeling of photoaffinity linkers correlates with their molecular shapes in living cells H Park, JY Koo, YV Srikanth, S Oh, J Lee, J Park, SB Park Chemical Communications 52 (34), 5828-5831, 2016 | 31 | 2016 |
Development of a Benzopyran‐Containing Androgen Receptor Antagonist to Treat Antiandrogen‐Resistant Prostate Cancer S Oh, HJ Nam, J Park, SH Beak, SB Park ChemMedChem: Chemistry Enabling Drug Discovery 5 (4), 529-533, 2010 | 28 | 2010 |
Discovery of a novel benzopyranyl compound as a potent in vitro and in vivo osteogenic agent S Oh, SW Cho, JY Yang, HJ Sun, YS Chung, CS Shin, SB Park MedChemComm 2 (1), 76-80, 2011 | 19 | 2011 |
Role of chemical biology in tuberculosis drug discovery and diagnosis K Kolbe, SK Veleti, EE Johnson, YW Cho, S Oh, CE Barry III ACS infectious diseases 4 (4), 458-466, 2018 | 17 | 2018 |
Benzothiazepinecarboxamides: novel hepatitis C virus inhibitors that interfere with viral entry and the generation of infectious virions HY Kim, S Kong, S Oh, J Yang, E Jo, Y Ko, SH Kim, JY Hwang, R Song, ... Antiviral Research 129, 39-46, 2016 | 14 | 2016 |
Inhibition of CorA-dependent magnesium homeostasis is cidal in Mycobacterium tuberculosis Y Park, YM Ahn, S Jonnala, S Oh, JM Fisher, MB Goodwin, TR Ioerger, ... Antimicrobial Agents and Chemotherapy 63 (10), 10.1128/aac. 01006-19, 2019 | 13 | 2019 |
Total synthesis of eryvarin H and its derivatives and their biological activity as ERRγ inverse agonist JY Koo, S Oh, SR Cho, M Koh, WK Oh, HS Choi, SB Park Organic & Biomolecular Chemistry 11 (35), 5782-5786, 2013 | 13 | 2013 |
Resistance of Mycobacterium tuberculosis to indole 4-carboxamides occurs through alterations in drug metabolism and tryptophan biosynthesis MDJ Libardo, CJ Duncombe, SR Green, PG Wyatt, S Thompson, PC Ray, ... Cell Chemical Biology 28 (8), 1180-1191. e20, 2021 | 12 | 2021 |